The role of vaccines in preventing bacterial antimicrobial resistance

The antibiotic resistance crisis: part 1: causes and threats.

Ventola, C. L. (2015) · PubMed · Cited by 4,516

Antibacterial resistance worldwide: causes, challenges and responses

Levy, S. B., & Marshall, B. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,052

Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pepin, J., & Wilcox, M. H. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,942

Untitled work

(2016) · Cited by 2,888

The crisis in antibiotic resistance

Neu, H. C. (1992) · Science · doi:10.1126/science.257.5073.1064 · Cited by 2,834

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

Nair, H., Nokes, D. J., Gessner, B. D., Dherani, M., Madhi, S. A., Singleton, R. J., O'Brien, K. L., Roca, A., Wright, P. F., Bruce, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60206-1 · Cited by 2,773

Characterization of a New Metallo-β-Lactamase Gene, bla NDM-1 , and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India

Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519

Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults

Falsey, A. R., Hennessey, P. A., Formica, M. A., Cox, C., & Walsh, E. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043951 · Cited by 2,226

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility

Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984

Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011

Fleming-Dutra, K. E., Hersh, A. L., Shapiro, D. J., Bartoces, M., Enns, E. A., File, T. M., Finkelstein, J. A., Gerber, J. S., Hyun, D. Y., Linder, J. A., et al. (2016) · JAMA · doi:10.1001/jama.2016.4151 · Cited by 1,740

Risk of Primary Infection and Reinfection With Respiratory Syncytial Virus

Glezen, W. P. (1986) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1986.02140200053026 · Cited by 1,527

Overview of Nosocomial Infections Caused by Gram-Negative Bacilli

Weinstein, R. A., Gaynes, R., Edwards, J. R., & System, N. N. I. S. (2005) · Clinical Infectious Diseases · doi:10.1086/432803 · Cited by 1,404

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333

Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study

Walsh, T. R., Weeks, J., Livermore, D. M., & Toleman, M. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70059-7 · Cited by 1,250

A Review of Antibiotic Use in Food Animals: Perspective, Policy, and Potential

Landers, T. F., Cohen, B., Wittum, T. E., & Larson, E. L. (2012) · Public Health Reports® · doi:10.1177/003335491212700103 · Cited by 1,241

The contribution of vaccination to global health: past, present and future

Greenwood, B. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0433 · Cited by 979

Herd Immunity: History, Theory, Practice

Fine, P. E. M. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036121 · Cited by 905

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

Wilcox, M. H., Gerding, D. N., Poxton, I. R., Kelly, C., Nathan, R., Birch, T., Cornely, O. A., Rahav, G., Bouza, E., Lee, C., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1602615 · Cited by 858

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

COMMITTEE ON INFECTIOUS DISEASES AND BRONCHIOLITIS GUIDELINES COMMITTEE, Brady, M. T., Byington, C. L., Davies, H. D., Edwards, K. M., Jackson, M. A., Maldonado, Y. A., Murray, D. L., Orenstein, W. A., Rathore, M. H., et al. (2014) · Pediatrics · doi:10.1542/peds.2014-1665 · Cited by 771

Emergence and global spread of epidemic healthcare-associated Clostridium difficile

He, M., Miyajima, F., Roberts, P., Ellison, L., Pickard, D. J., Martin, M. J., Connor, T. R., Harris, S. R., Fairley, D., Bamford, K. B., et al. (2013) · Nature Genetics · doi:10.1038/ng.2478 · Cited by 735

The Relationship between Antimicrobial Use and Antimicrobial Resistance in Europe

Bronzwaer, S. L. A. M., Cars, O., Buchholz, U., Mölstad, S., Goettsch, W., Veldhuijzen, I. K., Kool, J. L., Sprenger, M. J. W., Degener, J. E., & System, P. I. T. E. A. R. S. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0803.010192 · Cited by 690

The Development of Vancomycin Resistance in a Patient with Methicillin-Resistant Staphylococcus aureus Infection

Sieradzki, K., Roberts, R. B., Haber, S. W., & Tomasz, A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400704 · Cited by 638

Hospitalizations Associated With Influenza and Respiratory Syncytial Virus in the United States, 1993–2008

Zhou, H., Thompson, W. W., Viboud, C. G., Ringholz, C. M., Cheng, P.-Y., Steiner, C., Abedi, G. R., Anderson, L. J., Brammer, L., & Shay, D. K. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis211 · Cited by 573

Emergence of Drug-Resistant Pneumococcal Infections in the United States

Breiman, R. F. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510470035031 · Cited by 562

Antimicrobial Resistance in Haemophilus influenzae

Tristram, S., Jacobs, M. R., & Appelbaum, P. C. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-06 · Cited by 464

Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera

Ngwuta, J. O., Chen, M., Modjarrad, K., Joyce, M. G., Kanekiyo, M., Kumar, A., Yassine, H. M., Moin, S. M., Killikelly, A. M., Chuang, G.-Y., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac4241 · Cited by 431

Rates of Hospitalizations for Respiratory Syncytial Virus, Human Metapneumovirus, and Influenza Virus in Older Adults

Widmer, K., Zhu, Y., Williams, J. V., Griffin, M. R., Edwards, K. M., & Talbot, H. K. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis309 · Cited by 364

Escherichia coli Harboring mcr-1 and bla CTX-M on a Novel IncF Plasmid: First Report of mcr-1 in the United States

McGann, P., Snesrud, E., Maybank, R., Corey, B., Ong, A. C., Clifford, R., Hinkle, M., Whitman, T., Lesho, E., & Schaecher, K. E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01103-16 · Cited by 350

Scaling up interventions to achieve global tuberculosis control: progress and new developments

Raviglione, M., Marais, B., Floyd, K., Lönnroth, K., Getahun, H., Migliori, G. B., Harries, A. D., Nunn, P., Lienhardt, C., Graham, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60727-2 · Cited by 340

Vaccination with FimH Adhesin Protects Cynomolgus Monkeys from Colonization and Infection by Uropathogenic Escherichia coli

Langermann, S., Möllby, R., Burlein, J. E., Palaszynski, S. R., Auguste, C. G., DeFusco, A., Strouse, R., Schenerman, M. A., Hultgren, S. J., Pinkner, J. S., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315258 · Cited by 336

Respiratory viral infection predisposing for bacterial disease: a concise review.

Hament, J.-M., Kimpen, J. L. L., Fleer, A., & Wolfs, T. F. W. (1999) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1999.tb01389.x · Cited by 306

Adherence to Surgical Care Improvement Project Measures and Post-Operative Surgical Site Infections

Awad, S. S. (2012) · Surgical Infections · doi:10.1089/sur.2012.131 · Cited by 280

Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing

Peng, Z., Jin, D., Kim, H. B., Stratton, C. W., Wu, B., Tang, Y.-W., & Sun, X. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.02250-16 · Cited by 259

Extraintestinal Pathogenic Escherichia coli , a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field

Poolman, J. T., & Wacker, M. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv429 · Cited by 246

Protective and Harmful Immunity to RSV Infection

Openshaw, P. J. M., Chiu, C., Culley, F. J., & Johansson, C. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052206 · Cited by 243

A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail

Goff, D. A., Kullar, R., Goldstein, E. J. C., Gilchrist, M., Nathwani, D., Cheng, A. C., Cairns, K. A., Escandón-Vargas, K., Villegas, M. V., Brink, A., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30386-3 · Cited by 233

How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?

Lipsitch, M., & Siber, G. R. (2016) · mBio · doi:10.1128/mbio.00428-16 · Cited by 225

Prevention of tuberculosis in Bacille Calmette–Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine

von Reyn, C. F., Mtei, L., Arbeit, R. D., Waddell, R., Cole, B., Mackenzie, T., Matee, M., Bakari, M., Tvaroha, S., Adams, L. V., et al. (2010) · AIDS · doi:10.1097/qad.0b013e3283350f1b · Cited by 220

Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review

Kaufmann, S. H. E., Lange, C., Rao, M., Balaji, K. N., Lotze, M., Schito, M., Zumla, A. I., & Maeurer, M. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70033-5 · Cited by 217

Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial

Huttner, A., Hatz, C., van den Dobbelsteen, G., Abbanat, D., Hornacek, A., Frölich, R., Dreyer, A. M., Martin, P., Davies, T., Fae, K., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30108-1 · Cited by 206

Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study

Moore, M. R., Link-Gelles, R., Schaffner, W., Lynfield, R., Holtzman, C., Harrison, L. H., Zansky, S. M., Rosen, J. B., Reingold, A., Scherzinger, K., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)00052-7 · Cited by 194

How do viral infections predispose patients to bacterial infections?

Beadling, C., & Slifka, M. K. (2004) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200406000-00003 · Cited by 183

The Role of Viral, Host, and Secondary Bacterial Factors in Influenza Pathogenesis

Kash, J. C., & Taubenberger, J. K. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.08.030 · Cited by 178

Estimates of mortality attributable to influenza and RSV in the United States during 1997–2009 by influenza type or subtype, age, cause of death, and risk status

Matias, G., Taylor, R., Haguinet, F., Schuck‐Paim, C., Lustig, R., & Shinde, V. (2014) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12258 · Cited by 177

NATIONAL NOSOCOMIAL INFECTIONS SURVEILLANCE S. OVERVIEW OF NOSOCOMIAL INFECTIONS CAUSED BY GRAM-NEGATIVE BACILLI

Gaynes, R. P., & Edwards, J. R. (2005) · Cited by 176

Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: Evidence for herd effects and strain replacement due to Hib vaccination

Adam, H. J., Richardson, S. E., Jamieson, F. B., Rawte, P., Low, D. E., & Fisman, D. N. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.03.075 · Cited by 167

Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention

Dayan, G. H., Mohamed, N., Scully, I. L., Cooper, D., Begier, E. M., Eiden, J., Jansen, K. U., Gurtman, A., & Anderson, A. S. (2016) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1179583 · Cited by 162

The Effect of Universal Influenza Immunization on Antibiotic Prescriptions: An Ecological Study

Kwong, J. C., Maaten, S., Upshur, R. E. G., Patrick, D. M., & Marra, F. (2009) · Clinical Infectious Diseases · doi:10.1086/605087 · Cited by 159

Impact of Prematurity and Perinatal Antibiotics on the Developing Intestinal Microbiota: A Functional Inference Study

Arboleya, S., Sánchez, B., Sánchez, G. S., Fernández, N., Suárez, M., Hernández‐Barranco, A. M., Milani, C., Margollés, A., Reyes‐Gavilán, C. G. D. L., Ventura, M., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050649 · Cited by 155

Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine

Tomczyk, S. M., Lynfield, R., Schaffner, W., Reingold, A. L., Miller, L. A., Petit, S., Holtzman, C., Zansky, S. M., Thomas, A. R., Baumbach, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw067 · Cited by 154

Diversity of Ampicillin-Resistance Genes in Haemophilus influenzae in Japan and the United States

Hasegawa, K., Yamamoto, K., Chiba, N., Kobayashi, R., Nagai, K., Jacobs, M. R., Appelbaum, P. C., Sunakawa, K., & Ubukata, K. (2003) · Microbial Drug Resistance · doi:10.1089/107662903764736337 · Cited by 152

Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease

Yildirim, I. B., Hanage, W. P., Lipsitch, M., Shea, K. M., Stevenson, A. E., Finkelstein, J. A., Huang, S. S., Lee, G. M., KLEINMAN, K. P., & Pelton, S. I. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.10.032 · Cited by 138

Prevention of Antibiotic-Nonsusceptible Streptococcus pneumoniae With Conjugate Vaccines

Hampton, L. M., Farley, M. M., Schaffner, W., Thomas, A. R., Reingold, A. L., Harrison, L. H., Lynfield, R., Bennett, N. M., Petit, S., Gershman, K. A., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir755 · Cited by 131

Vaccines against gonorrhea: Current status and future challenges

Jerse, A. E., Bash, M. C., & Russell, M. W. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.08.067 · Cited by 121

Respiratory Syncytial Virus Infection

Walsh, E. E. (2016) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2016.11.010 · Cited by 119

Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme

Hargreaves, R. M., Slack, M., Howard, A., Anderson, E., & Ramsay, M. E. (1996) · BMJ · doi:10.1136/bmj.312.7024.160 · Cited by 99

Siderophore vaccine conjugates protect against uropathogenic Escherichia coli urinary tract infection

Mike, L. A., Smith, S. N., Sumner, C. A., Eaton, K. A., & Mobley, H. L. T. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606324113 · Cited by 99

Staphylococcal Vaccines and Immunotherapies

Schaffer, A. C., & Lee, J. C. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2008.10.005 · Cited by 98

Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial

de Bruyn, G., Saleh, J., Workman, D., Pollak, R. A., Elinoff, V., Fraser, N. J., Lefebvre, G., Martens, M. G., Mills, R. E., Nathan, R., et al. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.03.028 · Cited by 95

Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers

Bézay, N., Ayad, A., Dubischar, K. L., Firbas, C., Hochreiter, R., Kiermayr, S., Kiss, I., Pinl, F., Jilma, B., & Westritschnig, K. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.03.098 · Cited by 95

Staphylococcus aureusantigens and challenges in vaccine development

Middleton, J. R. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.6.805 · Cited by 90

Decreasing Prevalence of β-Lactamase Production among Respiratory Tract Isolates of Haemophilus influenzae in the United States

Heilmann, K. P., Rice, C., Miller, A. L., Miller, N. J., Beekmann, S. E., Pfaller, M. A., Richter, S. S., & Doern, G. V. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2561-2564.2005 · Cited by 81

Perspective: A Five‐Country Analysis of the Impact of Four Different Haemophilus influenzae Type b Conjugates and Vaccination Strategies in Scandinavia

Peltola, H., Aavitsland, P., Hansen, K. G., Jónsdóttir, K., Nøkleby, H., & Romanus, V. (1999) · The Journal of Infectious Diseases · doi:10.1086/314535 · Cited by 81

Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines— Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High‐Risk Elderly Individuals

Falsey, A. R., Walsh, E. E., Capellan, J., Gravenstein, S., Zambon, M. C. F. A., Yau, E., Gorse, G. J., Edelman, R., Hayden, F. G., McElhaney, J. E., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/592168 · Cited by 81

Impact of pneumococcal conjugate vaccines for children in high- and non–high-income countries

Cohen, R., Cohen, J. F., Chalumeau, M., & Lévy, C. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1320221 · Cited by 81

Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands

Knol, M. J., Wagenvoort, G. H. J., Sanders, E. A. M., Elberse, K. E. M., Vlaminckx, B. J. M., de Melker, H. E., & ENDE, A. V. D. (2015) · Emerging infectious diseases · doi:10.3201/eid2111.140780 · Cited by 74

A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults

Sheldon, E. A., Kitchin, N. R. E., Peng, Y., Eiden, J., Gruber, W. C., Johnson, E. W., Jansen, K. U., Pride, M. W., & Pedneault, L. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.03.010 · Cited by 69

A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women

Leroux-Roels, G. G., Maes, C., Willekens, J., Boever, F. D., de Rooij, R., Martell, L., Bedell, L., Wittke, F., Slobod, K. S., & Dull, P. M. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.02.044 · Cited by 68

One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A

Mancini, F., Monaci, E., Lofano, G., Torre, A., Bacconi, M., Tavarini, S., Sammicheli, C., Arcidiacono, L., Galletti, B., Laera, D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147767 · Cited by 67

Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study

Frenck, R. W., Creech, C. B., Sheldon, E. A., Seiden, D., Kankam, M. K., Baber, J., Zito, E. T., Hubler, R., Eiden, J., Severs, J. M., et al. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.11.010 · Cited by 65

Epidemiology, virulence factors and management of the pneumococcus

Feldman, C. H., & Anderson, R. (2016) · F1000Research · doi:10.12688/f1000research.9283.1 · Cited by 64

Effect of a Best-Practice Alert on the Rate of Influenza Vaccination of Pregnant Women

Klatt, T. E., & Hopp, E. E. (2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e318242032a · Cited by 63

Effectiveness of Inactivated Influenza Vaccine for Prevention of Otitis Media in Children

Ozgur, S. K., Beyazova, U., Kemaloğlu, Y. K., Maral, İ., Şahin, F., Çamurdan, A. D., Kızıl, Y., Dinç, E., & Tüzün, H. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000217370.83948.51 · Cited by 62

Life-Threatening Haemophilus influenzae Infections in Scandinavia: A Five-Country Analysis of the Incidence and the Main Clinical and Bacteriologic Characteristics

Peltola, H., Rød, T. O., Jónsdóttir, K., Bötttger, M., & Coolidge, J. A. S. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.4.708 · Cited by 59

Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models

van den Dobbelsteen, G. P. J. M., Fae, K. C., Serroyen, J., van den Nieuwenhof, I. M., Braun, M., Haeuptle, M. A., Sirena, D., Schneider, J., Alaimo, C., Lipowsky, G., et al. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.06.067 · Cited by 54

Respiratory syncytial virus vaccine: a systematic overview with emphasis on respiratory syncytial virus subunit vaccines

Simões, E. A. F., Tan, D. H. S., Ohlsson, A., Sales, V., & Wang, E. E. L. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00388-7 · Cited by 53

Emergence of Amoxicillin-Resistant Variants of Spain9V-ST156 Pneumococci Expressing Serotype 11A Correlates with Their Ability to Evade the Host Immune Response

Aguinagalde, L., Corsini, B., Domenech, A., Domenech, M., Cámara, J., Ardanuy, C., Garcı́a, E., Liñares, J., Fenoll, A., & Yuste, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137565 · Cited by 52

Identification and characterization of antigens as vaccine candidates againstKlebsiella pneumoniae

Lundberg, U., Senn, B. M., Schüler, W., Meinke, A. L., & Hanner, M. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.23225 · Cited by 49

Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia—Implications for Vaccine Design

Rey-Jurado, E., & Kalergis, A. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030556 · Cited by 42

Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae

Tängdén, T., Eriksson, B., Melhus, Å., Svennblad, B., & Cars, O. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr053 · Cited by 37

Vaccine development to preventStaphylococcus aureussurgical-site infections

Mohamed, N., Wang, M., Huec, J.-C. L., Liljenqvist, U., Scully, I. L., Baber, J., Begier, E. M., Jansen, K. U., Gurtman, A., & Anderson, A. S. (2017) · British journal of surgery · doi:10.1002/bjs.10454 · Cited by 31

A comparison of intestinal microbiota in a population of low-risk infants exposed and not exposed to intrapartum antibiotics: The Baby & Microbiota of the Intestine cohort study protocol

Simioni, J. C., Hutton, E. K., Gunn, E., Holloway, A. C., Stearns, J. C., McDonald, H., Mousseau, A., Schertzer, J. D., Ratcliffe, E. M., Thabane, L., et al. (2016) · BMC Pediatrics · doi:10.1186/s12887-016-0724-5 · Cited by 24

Antibiotic Resistance

Coates, A. R. M. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-28951-4 · Cited by 16

Invasive group B streptococcal disease in an orthopaedic unit

Jenkins, P. J., Clement, N. D., Gaston, P., Breusch, S. J., Simpson, H., & Dave, J. (2010) · Journal of Hospital Infection · doi:10.1016/j.jhin.2010.06.011 · Cited by 13

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02724-0 · Cited by 16,316

Antimicrobial Resistance in ESKAPE Pathogens

De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078

Antibiotic resistance: turning evolutionary principles into clinical reality

Andersson, D. I., Balaban, N. Q., Baquero, F., Courvalin, P., Glaser, P., Gophna, U., Kishony, R., Molin, S., & Tønjum, T. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa001 · Cited by 238

‘It's cheaper than a dead cow’: Understanding veterinary medicine use on dairy farms

Rees, G. M., Reyher, K. K., Barrett, D. C., & Buller, H. (2021) · Journal of Rural Studies · doi:10.1016/j.jrurstud.2021.07.020 · Cited by 34

How COVID-19 Has Influenced Public Interest in Antimicrobials, Antimicrobial Resistance and Related Preventive Measures: A Google Trends Analysis of Italian Data

Maugeri, A., Barchitta, M., Basile, G., & Agodi, A. (2022) · Antibiotics · doi:10.3390/antibiotics11030379 · Cited by 13